SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
43 hedge funds and large institutions have $67.3M invested in Sinovac Biotech, Ltd in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 21 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
43% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 21
Holders
43
Holding in Top 10
–
Calls
$76K
Puts
$85K
Top Buyers
| 1 | +$682K | |
| 2 | +$607K | |
| 3 | +$204K | |
| 4 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$182K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$47.9K |
Top Sellers
| 1 | -$469K | |
| 2 | -$410K | |
| 3 | -$317K | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$300K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$270K |